1 / 4

Relative Valuation IIIa

Relative Valuation IIIa. Which multiple should you use in relative valuation?.

teva
Download Presentation

Relative Valuation IIIa

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Relative Valuation IIIa

  2. Which multiple should you use in relative valuation? You can do relative valuation using a variety of multiples, ranging from earnings multiples to book value multiples to revenue multiples. Assume that you are trying to do a relative valuation of Zyloft, a software company and are trying to decide which multiple to use in your valuation. Which one should you choose? • The multiple that yields the highest R-squared in a regression • I won’t pick one. I will take an average across the different values (from different multiples) • The multiple that most other analysts & investors tracing this company use. • The multiple that yields a value that best fits what I am trying to do with the valuation (show that it is cheap, expensive or correctly values) • None of the above

  3. Relative versus Intrinsic valuatoin You have just completed an intrinsic valuation of Zyloft Inc., a publicly traded software company and arrived at a value of $10/share and the stock is trading at $15. You value Zyloft, using a PE ratio against other software companies and estimate a value per share of $20. Based on these numbers, you would conclude that • The stock is under valued (its price < relative value) • The stock is over valued (its price > intrinsic value) • The stock is correctly valued (its price = average of relative & intrinsic value) • The stock is both under and over valued. • None of the above Explain.

  4. Peer group versus Market relative valuation Now assume that you value Zyloft using a market regression for PE and arrive at a value per share of $10 again. (Remember the price is $15/share and the relative valuation against software companies yielded $20/share). Based on these numbers, you would conclude that • The stock is under valued (its price < peer group relative value) • The stock is over valued (its price > market relative value) • The stock is correctly valued (its price = average of peer & market relative values) • The stock is both under and over valued • None of the above Explain.

More Related